Company Filing History:
Years Active: 1998-2004
Title: Kerry Ann Gagnon: Innovator in Bioreactor and Encapsulation Technologies
Introduction
Kerry Ann Gagnon is a notable inventor based in Danvers, MA (US). She has made significant contributions to the fields of bioreactor technology and drug delivery systems. With a total of 3 patents to her name, Gagnon continues to push the boundaries of innovation in her field.
Latest Patents
One of Gagnon's latest inventions is the Dual Fiber Bioreactor. This cell culture unit features a shell with two ends and an elongated chamber in between. It includes liquid and gas perfusion ports at each end, with liquid perfusion fibers connected to the liquid ports and gas perfusion fibers connected to the gas ports. This design creates both extracapillary and intracapillary spaces, enhancing the efficiency of cell culture processes.
Another significant invention is the Encapsulation Device. This device is designed to receive a bioactive agent and includes a biocompatible and semi-permeable membrane that defines an enclosed space. The membrane has an opening for introducing the bioactive agent, and in one embodiment, it features a biocompatible adhesive to seal the opening after the agent is introduced. This device is intended for placement in an animal, showcasing Gagnon's commitment to advancing medical technologies.
Career Highlights
Throughout her career, Gagnon has worked with several prominent companies, including Circe Biomedical, Inc. and W.R. Grace & Co. These experiences have allowed her to refine her skills and contribute to innovative projects in the biomedical field.
Collaborations
Gagnon has collaborated with talented individuals such as Claudy Jean Mullon and Christine Marie Tosone. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Kerry Ann Gagnon is a pioneering inventor whose work in bioreactor and encapsulation technologies has the potential to transform medical practices. Her innovative spirit and dedication to research continue to inspire advancements in the field.